|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 237/16 | (2006.01) |
| A61K 31/50 | (2006.01) | ||
| A61P 3/00 | (2006.01) | ||
| A61P 9/00 | (2006.01) |
| (11) | Number of the document | 4406594 |
| (13) | Kind of document | T |
| (96) | European patent application number | 24173563.8 |
| Date of filing the European patent application | 2013-09-17 | |
| (97) | Date of publication of the European application | 2024-07-31 |
| (45) | Date of publication and mention of the grant of the patent | 2025-09-10 |
| (46) | Date of publication of the claims translation | 2025-12-29 |
| (30) | Number | Date | Country code |
| 201261702137 P | 2012-09-17 | US | |
| 201361790432 P | 2013-03-15 | US |
| (72) |
HESTER, Keith D. , US
DUGUID, Robert J. , US
KELLY, Martha , US
CHASNOFF, Anna , US
DONG, Gang , US
CROW, Edwin L. , US
TAUB, Rebecca , US
REYNOLDS, Charles H. , US
CHOI, Duk Soon , US
SHU, Lianhe , US
WANG, Ping , US
|
| (73) |
Madrigal Pharmaceuticals, Inc. ,
200 Barr Harbor Drive
Suite 200, West Conshohocken, PA 19428,
US
F. Hoffmann-La Roche Ltd , Grenzacherstrasse 124, 4070 Basel, CH |
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Skydliaukės hormono analogai |
| THYROID HORMONE ANALOGS |
| Payment date | Validity (years) | Amount | |
| 2025-11-03 | 13 | 289.00 EUR |
| 2026-09-17 |